ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Non Active Desensitization Protocol: Improving Access to Kidney Transplant for Hyperimmunized Patients

    S. Le Bot,1 F. Delbos,2 C. Garandeau,1 S. Malard Castagnet,2 A. Cesbron,2 M. Hourmant.1

    1Nephrology and Transplantation, CHU Hôtel Dieu, Nantes, France; 2Laboratoire HLA, Etablissement Français du Sang, Nantes, France.

    Hyperimmunized patients have a bad access to renal transplantation, despite national priority programs and active desensitization protocols. After having noticed that some HLA antibodies decreased…
  • 2018 American Transplant Congress

    Impact of Pneumocystis Prophylaxis on Incidence of Treated Urinary Tract Infections Following Kidney Transplantation

    S. Sanchez, M. Brokhof, N. Kenyon, C. Varughese, N. Alvey.

    Rush University Medical Center, Chicago, IL.

    Background: Urinary tract infection (UTI) is the most common infectious complication after kidney transplantation resulting in increased morbidity and mortality. Sulfamethoxazole[mdash]trimethoprim (SMX-TMP) is commonly used…
  • 2018 American Transplant Congress

    Cryptococcal Infections in Kidney Transplant Recipients. A Single Center Experience

    M. Radisic,1 N. Pujato,1 A. Dotta,2 R. Livia Franzini,2 M. Bravo,1 L. Rodriguez Rilo,1 C. Giampieri,2 L. Leon,1 M. Rial,1 D. Casadei.1

    1Infectious Diseases, Instituto de Nefrologia de Buenos Aires, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina; 2Kidney Transplantation, Instituto de Nefrologia de Buenos Aires, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina.

    Cryptococcal infections are infrequent but a cause of morbidity & mortality in transplant (T) recipients. Best treatment and the need for secondary prophylaxis are still…
  • 2018 American Transplant Congress

    Bariatric Surgery before and after Kidney Transplantation: Long-Term Weight-Loss and Allograft Outcomes

    J. Cohen, M. Lim, C. Tewksbury, S. Torres Landa, J. Trofe-Clark, P. Abt, N. Williams, K. Dumon, S. Goral.

    University of Pennsylvania, Philadelphia.

    Obesity, a critical public health issue affecting >25% of kidney transplant (KTX) candidates, is often a barrier to transplantation. Bariatric surgery is an important tool…
  • 2018 American Transplant Congress

    The Impact of Anticoagulation Therapy Modifications during the Index Hospitalization on Clinical Outcomes in Kidney Transplant Recipients

    J. Hardcopf, H. Meadows, N. Pilch, C. Perez, N. Patel, J. Fleming, H. Corbo, T. Harrison, B. O'Brien, D. DuBay, P. Baliga, D. Taber.

    Medical University of South Carolina, Charleston, SC.

    Background: The aim of this study was to determine whether changing anticoagulation medications during the index admission for kidney transplant (KT) is significantly associated with…
  • 2018 American Transplant Congress

    Impact of Balanced Solutions on Acid Base Disorders during and after Kidney Transplantation

    N. Maillard,2 H. Chraka,1 G. Claisse,2 E. Alamartine,2 S. Molliex,1 C. Mariat.2

    1Département d'Anesthésie Réanimation, CHU Saint Etienne, Saint Etienne, France; 2Service de Néphrologie Dialyse Transplantation Rénale, CHU Saint Etienne, Saint Etienne, France.

    Fluid management of peri operative period of kidney transplantation is crucial to drive volemia, acid/base and electrolyte balance, as renal function is usually absent or…
  • 2018 American Transplant Congress

    Preemptive Chest Tube in Liver Transplantation – An Unconventional Way to Reduce Morbidity

    P. Ritschl, L. Wiering, F. Sponholz, A. Brandl, F. Aigner, M. Biebl, M. Schmelzle, D. Eurich, I. Sauer, K. Kotsch, J. Pratschke, R. Öllinger.

    Department of Surgery, Campus Charité Mitte / Campus Virchow-Klinikum CCM/CVK, Charité - Universtitätsmedizin Berlin, Berlin, Germany.

    For various reasons, liver recipients are frequently affected by pleural effusions in the postoperative phase. Besides high volume turn over and low serum albumin, local…
  • 2018 American Transplant Congress

    Incidence Trends among Deceased Liver Transplant Recipients in the United States, 2011-2016: A Propensity Score-Matched Study

    R. Schilke, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.

    Transplant Institute, Henry Ford Hospital, Detroit, MI.

    BackgroundDonation after cardiac death (DCD) donor liver graft is a known risk factor for graft failure secondary to primary non-function (PNF) and/or diffuse cholangiopathy (DC).…
  • 2018 American Transplant Congress

    Is Percent Exception at Transplant a Driver of MELD Inflation?

    D. Schladt,1 J. Snyder,1 A. Israni,1 W. Kim,2 J. Lake.3

    1SRTR, Minneapolis, MN; 2Stanford University, Stanford, CA; 3Univ of Minnesota, Minneapolis, MN.

    Before 2016, the proportion of deceased donor liver recipients with an exception status at liver transplant (LT) correlated strongly with median MELD at transplant (MMaT)…
  • 2018 American Transplant Congress

    Outcomes of Moderately Macrosteatotic Liver Allografts

    J. Alvikas, A-.P. Deeb, K. Lemon, X. Chen, S. Malik, G. Zeng, C. Hughes, A. Humar, A. Tevar.

    Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA.

    Objectives: Liver transplantation remains the only effective long-term treatment option for patients with end-stage liver disease (ESLD). Organs available for ESLD patients are scarce and…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences